Yu-Waye Chu
Overview
Yu-Waye Chu received $6M in total compensation, including $430K in salary, at Fate Therapeutics in 2021.
Source: SEC filing on April 25, 2022.
Related executives
We found ten more executives who work or worked at Fate Therapeutics.
J Wolchko
Fate Therapeutics
Chief Executive Officer
Mark Plavsic
Fate Therapeutics
Chief Technology Officer
Bahram Valamehr
Fate Therapeutics
Chief Research and Development Officer
Cindy Tahl
Fate Therapeutics
General Counsel
Edward Dulac
Fate Therapeutics
Chief Financial Officer
Daniel Shoemaker
Fate Therapeutics
Chief Scientific Officer
Christopher Storgard
Fate Therapeutics
Chief Medical Officer
Stewart Abbot
Fate Therapeutics